Navigation Links
National Jewish Health receives patent for diagnostic method of autoimmune chronic urticaria
Date:11/1/2010

National Jewish Health has received a US patent for a method of detecting autoimmune chronic urticaria, which will help assure many patients that dramatic changes in lifestyle are not needed to treat the condition. Ronald Harbeck, PhD, Medical Director of the Advanced Diagnostic Laboratories at National Jewish Health, and colleagues Drs. Karen Andrews and Donald MacGlashan, Jr. developed the diagnostic assay, which makes use of the protein CD203c as a marker for the condition. The test, offered by the diagnostic laboratories at National Jewish Health, has been highly successful, with 250 to 300 tests run every week for patients around the nation.

Chronic urticaria is recurrent hives that last for six weeks or longer. They can be caused by allergic and non-allergic reactions. It is often difficult to pin down a specific cause. Without a known cause, many patients will try various adjustments to their lifestyles in an often unsuccessful attempt to cure the hives.

"Patients will often try eliminating foods from their diet or pets from their homes and alter their medications, believing they are suffering from allergic reactions," said Dr. Harbeck.

Approximately 40 percent of chronic urticaria patients have an autoimmune form of the disease, which is essentially a malfunction of the immune system and has no external cause. Doctors can prescribe a variety of treatments for chronic urticaria, based on symptoms, but rarely prescribe a significant change in lifestyle. The recently granted patent describes a method for detecting this autoimmune form of chronic urticaria.

"This diagnostic method will allow some patients to continue their normal, daily lives knowing that they are not suffering from an allergic condition," said Dr. Harbeck.

The invented method includes detecting the expression of the protein CD203c on cells in the presence of the antibody present in chronic urticaria patients.

"The creation of this diagnostic test is a reflection of the quality of research performed by our scientists and the commitment from National Jewish Health to support the advancement of research discoveries towards clinical applications in the spirit of our brand promise, Science Transforming Life," said Emmanuel Hilaire, PhD, Manager of the Technology Transfer Office at National Jewish Health.


'/>"/>

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Related medicine news :

1. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
2. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
3. National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal
4. Howard Dean to Speak at the 2010 DTC National Conference
5. International Diabetes Federation awards $2 million to 9 global diabetes research projects
6. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
7. U.S. National Guard Connects Nationwide with Desktop Alert's Command and Control Mass Notification Systems and Common Alerting Protocol (CAP)
8. H1N1 international symposium to be hosted by Emory-UGA Influenza Center
9. The Alliance for a Healthier Generation Names Celtics Captain Paul Pierce National Athlete Spokesperson in the Fight Against Childhood Obesity
10. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
11. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... this installment is bolstered by inspiring human interest stories, courtesy of leaders in ... trends and tech within the industry, from leading advocates and associations—namely Jones & ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare ... suppliers for its inaugural Member Conference at the Paris Hotel in Las Vegas, ... operational health of America’s healthcare providers. , The conference was highlighted by the ...
(Date:5/26/2016)... ... ... The Woodlands at John Knox Village , Florida’s first Life Plan ... and healing, celebrated its grand opening, today. The Woodlands at John Knox Village is ... Staff. , “This is an incredibly fulfilling time for John Knox Village as we ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... to support the company’s continued investment and strategic growth plans in the Asia ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior ... executive officer, today. In his new role, Marziani will lead the company,s business development ... professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
(Date:5/24/2016)... -- Open Access Journal Focusing on ... Elsevier , a world-leading provider of scientific, technical ... launch of Clinical Neurophysiology Practice ... clinical practice issues in clinical neurophysiology. The journal will ... and didactic reviews. It is an official journal of ...
Breaking Medicine Technology: